Reports for BUPRENORPHINE

Ingredient

BUPRENORPHINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUBLOCADE 300MG SOLUTION (EXTENDED RELEASE) Resolved 2020-09-01 2021-01-27 123466
SUBLOCADE 300MG SOLUTION (EXTENDED RELEASE) Resolved 2022-02-24 2022-03-03 155534
SUBLOCADE 100MG SOLUTION (EXTENDED RELEASE) Resolved 2020-09-01 2021-03-10 123461
BUTRANS 15 15MCG PATCH Resolved 2021-12-14 2022-02-05 151112
BUTRANS 5 5MCG PATCH Resolved 2021-05-13 2021-05-27 139259
BUTRANS 20 20MCG PATCH Resolved 2020-06-02 2020-06-17 116371
BUTRANS 20 20MCG PATCH Resolved 2022-05-20 2022-05-31 161051
BUTRANS 20 20MCG PATCH Resolved 2022-09-06 2022-09-16 168627
BUTRANS 20 20MCG PATCH Resolved 2023-02-03 2023-02-09 183517
BUTRANS 20 20MCG PATCH Resolved 2023-02-03 2023-02-17 183519

Showing 21 to 30 of 37

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Discontinued 2019-09-17 2019-09-18 94048
BELBUCA 75MCG FILM, SOLUBLE Discontinued 2019-03-28 2019-04-02 79766
BELBUCA 150MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80230
BELBUCA 300MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80233
BELBUCA 450MCG FILM, SOLUBLE Discontinued 2019-04-01 2019-04-02 80236
MYLAN-BUPRENORPHINE/NALOXONE Discontinued 2019-09-17 2019-09-18 94044

Showing 1 to 6 of 6